Novel Genome-Editing Tools to Model and Correct Primary Immunodeficiencies.

Fiche du document

Date

2015

Types de document
Périmètre
Langue
Identifiants
Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.3389/fimmu.2015.00250

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/26052330

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1664-3224

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_FEDC491D31128

Licences

info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer


Sujets proches En

Tools Hand tools Handtools

Citer ce document

L.M. Ott de Bruin et al., « Novel Genome-Editing Tools to Model and Correct Primary Immunodeficiencies. », Serveur académique Lausannois, ID : 10.3389/fimmu.2015.00250


Métriques


Partage / Export

Résumé 0

Severe combined immunodeficiency (SCID) and other severe non-SCID primary immunodeficiencies (non-SCID PID) can be treated by allogeneic hematopoietic stem cell (HSC) transplantation, but when histocompatibility leukocyte antigen-matched donors are lacking, this can be a high-risk procedure. Correcting the patient's own HSCs with gene therapy offers an attractive alternative. Gene therapies currently being used in clinical settings insert a functional copy of the entire gene by means of a viral vector. With this treatment, severe complications may result due to integration within oncogenes. A promising alternative is the use of endonucleases such as ZFNs, TALENs, and CRISPR/Cas9 to introduce a double-stranded break in the DNA and thus induce homology-directed repair. With these genome-editing tools a correct copy can be inserted in a precisely targeted "safe harbor." They can also be used to correct pathogenic mutations in situ and to develop cellular or animal models needed to study the pathogenic effects of specific genetic defects found in immunodeficient patients. This review discusses the advantages and disadvantages of these endonucleases in gene correction and modeling with an emphasis on CRISPR/Cas9, which offers the most promise due to its efficacy and versatility.

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Exporter en